156 related articles for article (PubMed ID: 3669002)
21. Synthesis of certain 2-aminoadamantane derivatives as potential antimicrobial agents.
Eisa HM; Tantawy AS; el-Kerdawy MM
Pharmazie; 1991 Mar; 46(3):182-4. PubMed ID: 1909034
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of some 3-substituted amino-4,5-tetramethylene thieno[2,3-d][ 1,2,3]-triazin-4(3H)-ones as potential antimicrobial agents.
Saravanan J; Mohan S; Roy JJ
Eur J Med Chem; 2010 Sep; 45(9):4365-9. PubMed ID: 20579782
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, β -catenin Translocation Capability and ALP Activation Activity of 7H-thiazolo[3,2-b]-1,2,4-triazin-7-one Derivatives.
Hou S; Xu H; Hu J; Hou J; Wang Y; Jin Z; Wan DCC; Hu C
Med Chem; 2018; 14(1):67-73. PubMed ID: 28969571
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and biological evaluation of 6-aryl-1,6-dihydro-1,3,5-triazine-2,4-diamines as antiplasmodial antifolates.
Lourens AC; Gravestock D; van Zyl RL; Hoppe HC; Kolesnikova N; Taweechai S; Yuthavong Y; Kamchonwongpaisan S; Rousseau AL
Org Biomol Chem; 2016 Aug; 14(33):7899-911. PubMed ID: 27477595
[TBL] [Abstract][Full Text] [Related]
25. [Studies on as-triazine derivatives. XVIII. Synthesis of 5,6-diaryl-1,2,4-triazine derivatives as blood platelet aggregation inhibitors].
Konno S; Kokubo T; Amano M; Yoshida N; Sagi M; Yamanaka H
Yakugaku Zasshi; 1992 Oct; 112(10):729-41. PubMed ID: 1469603
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of some new biologically active bis-(thiadiazolotriazines) and bis-(thiadiazolotriazinyl) alkanes.
Holla BS; Gonsalves R; Rao BS; Shenoy S; Gopalakrishna HN
Farmaco; 2001 Dec; 56(12):899-903. PubMed ID: 11829109
[TBL] [Abstract][Full Text] [Related]
27. 1-Aryl-4,6-diamino-1,2-dihydrotriazine as antimalarial agent: a new synthetic route.
Kidwai M; Mothsra P; Mohan R; Biswas S
Bioorg Med Chem Lett; 2005 Feb; 15(4):915-7. PubMed ID: 15686886
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, antimalarial activity and cytotoxicity of 4-aminoquinoline-triazine conjugates.
Manohar S; Khan SI; Rawat DS
Bioorg Med Chem Lett; 2010 Jan; 20(1):322-5. PubMed ID: 19910192
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and bioevaluation of hybrid 4-aminoquinoline triazines as a new class of antimalarial agents.
Kumar A; Srivastava K; Raja Kumar S; Puri SK; Chauhan PM
Bioorg Med Chem Lett; 2008 Dec; 18(24):6530-3. PubMed ID: 18951791
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, anti-HIV and anticancer activities of new 4-(2-mercaptobenzenesulfonyl)perhydro-1,2,4-triazin-3-ones.
Pomarnacka E
Acta Pol Pharm; 1998; 55(6):481-6. PubMed ID: 10073135
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and antiamoebic activity of 3,7-dimethyl-pyrazolo[3,4-e][1,2,4] triazin-4-yl thiosemicarbazide derivatives.
Singh S; Husain K; Athar F; Azam A
Eur J Pharm Sci; 2005 Jun; 25(2-3):255-62. PubMed ID: 15911221
[TBL] [Abstract][Full Text] [Related]
32. Design and synthesis of (5-amino-1, 2, 4-triazin-6-yl)(2-(benzo[d] isoxazol-3-yl) pyrrolidin-1-yl)methanone derivatives as sodium channel blocker and anticonvulsant agents.
Malik S; Khan SA
J Enzyme Inhib Med Chem; 2014 Aug; 29(4):505-16. PubMed ID: 23914929
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and in vitro anticancer evaluation of some 4,6-diamino-1,3,5-triazine-2-carbohydrazides as Rad6 ubiquitin conjugating enzyme inhibitors.
Kothayer H; Spencer SM; Tripathi K; Westwell AD; Palle K
Bioorg Med Chem Lett; 2016 Apr; 26(8):2030-4. PubMed ID: 26965855
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and anticancer activity of novel 2-amino-4-(4-phenylpiperazino)- 1,3,5-triazine derivatives.
Pomarnacka E; Bednarski P; Grunert R; Reszka P
Acta Pol Pharm; 2004; 61(6):461-6. PubMed ID: 15794339
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, antimalarial activity and molecular docking of hybrid 4-aminoquinoline-1,3,5-triazine derivatives.
Bhat HR; Singh UP; Thakur A; Kumar Ghosh S; Gogoi K; Prakash A; Singh RK
Exp Parasitol; 2015 Oct; 157():59-67. PubMed ID: 26164360
[TBL] [Abstract][Full Text] [Related]
36. 4-aminoquinoline-triazine-based hybrids with improved in vitro antimalarial activity against CQ-sensitive and CQ-resistant strains of Plasmodium falciparum.
Manohar S; Khan SI; Rawat DS
Chem Biol Drug Des; 2013 May; 81(5):625-30. PubMed ID: 23331618
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, Docking, In Vitro and In Vivo Antimalarial Activity of Hybrid 4-aminoquinoline-1,3,5-triazine Derivatives Against Wild and Mutant Malaria Parasites.
Bhat HR; Singh UP; Gahtori P; Ghosh SK; Gogoi K; Prakash A; Singh RK
Chem Biol Drug Des; 2015 Sep; 86(3):265-71. PubMed ID: 25487527
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and antimalarial activity of 2-guanidino-4-oxoimidazoline derivatives.
Liu X; Wang X; Li Q; Kozar MP; Melendez V; O'Neil MT; Lin AJ
J Med Chem; 2011 Jul; 54(13):4523-35. PubMed ID: 21627120
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of oxalamide and triazine derivatives as a novel class of hybrid 4-aminoquinoline with potent antiplasmodial activity.
Sunduru N; Sharma M; Srivastava K; Rajakumar S; Puri SK; Saxena JK; Chauhan PM
Bioorg Med Chem; 2009 Sep; 17(17):6451-62. PubMed ID: 19665899
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and in vivo antimalarial evaluation of isopropyl [(4-chlorophenyl)amino]iminomethylcarbamimidate.
Warner VD; Lynch DM; Meszoely CA; Dykstra WG
J Pharm Sci; 1977 Mar; 66(3):418-9. PubMed ID: 845808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
